Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 19 Jul 2020 |
2 | Journal Copy | 29 Sep 2020 |
3 | TM-O(NOTICE OF OPPOSITION) | 18 Dec 2020 |
4 | Order | 27 Oct 2022 |
1 | Opposition Notice | 10925533 | 5067169 | 06 Jan 2021 |
The application for Azopanib was made on 19 July 2020.
The trademark applicant for Azopanib is AUROBINDO PHARMA.
Azopanib is applied in class(es) 5.
Application for Azopanib is on Abandoned stage.
Application Id allotted to Azopanib is 4576002.
Trademark agent or attorney for the application is Daswani & Daswani.
Azopanib filed with the Intellectual property office as a WORD.